Towards reforming the taxonomy of human disease

Nature Reviews Drug Discovery

Volumn 14, Issue 2, 2015, Pages 75-76

  Hofmann Apitius, Martin ^a   Alarcón Riquelme, Marta E ^b   Chamberlain, Chris ^c   McHale, Duncan ^c  

^a FRAUNHOFER INSTITUTE FOR ALGORITHMS AND SCIENTIFIC COMPUTING SCAI   (Germany)

^b JUNTA DE ANDALUCÍA   (Spain)

^c UCB Celltech   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY;

ALZHEIMER DISEASE; AMYLOID PLAQUE; AUTOIMMUNE DISEASE; CLINICAL FEATURE; DATA MINING; DEGENERATIVE DISEASE; DISEASE CLASSIFICATION; DRUG RESEARCH; EPIGENETICS; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; INFLAMMATORY DISEASE; KNOWLEDGE BASE; MEMORY DISORDER; MOLECULAR BIOLOGY; NEUROFIBRILLARY TANGLE; NOTE; PARKINSON DISEASE; PERSONALIZED MEDICINE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; SCLERODERMA; SIGNAL TRANSDUCTION; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSLATIONAL RESEARCH; AUTOIMMUNE DISEASES; CLASSIFICATION; DRUG DEVELOPMENT; GENETICS; NEURODEGENERATIVE DISEASES;

AUTOIMMUNE DISEASES; CLASSIFICATION; DRUG DISCOVERY; HUMANS; INDIVIDUALIZED MEDICINE; NEURODEGENERATIVE DISEASES;

EID: 84926014373     PISSN: 14741776     EISSN: 14741784     Source Type: Journal    
DOI: 10.1038/nrd4537     Document Type: Note

References (3)

1. Kola, I., & Bell. J. A call to reform the taxonomy of human disease. Nature Rev. Drug Discov. 10, 641-642 (2011
2. Mok, T. S. et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N. Engl. J. Med. 361, 947-957 (2009
3. Chapman, P. B. et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med. 364, 2507-2516 (2011).